Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dicloxacillin
Drug ID BADD_D00657
Description One of the penicillins which is resistant to penicillinase.
Indications and Usage Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
Marketing Status approved; investigational; vet_approved
ATC Code J01CF01
DrugBank ID DB00485
KEGG ID D02348
MeSH ID D004009
PubChem ID 18381
TTD Drug ID D0R2KJ
NDC Product Code Not Available
UNII COF19H7WBK
Synonyms Dicloxacillin | Dicloxacycline | Dichloroxacillin | Dicloxaciclin | Diclocil | Dicloxacillin Sodium | Sodium, Dicloxacillin | Dicloxacillin, Monosodium Salt, Mono-Hydrate | Dicloxacillin, Monosodium Salt, Anhydrous | Dicloxsig | Distaph | Dycill | Dynapen | InfectoStaph | Pathocil | Posipen | Cilpen | Ditterolina
Chemical Information
Molecular Formula C19H17Cl2N3O5S
CAS Registry Number 3116-76-5
SMILES CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase increased13.03.04.005--
Anaemia01.03.02.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.04.011--
Body temperature increased13.15.01.001--Not Available
Bone disorder15.02.04.004--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Confusional state19.13.01.001; 17.02.03.005--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dyspepsia07.01.02.001--
Eosinophilia01.02.04.001--
Epilepsy17.12.03.002--Not Available
Feeling abnormal08.01.09.014--Not Available
Flatulence07.01.04.002--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Haematuria21.10.01.018; 24.07.01.047; 20.02.01.006--
Haemolytic anaemia01.06.03.002--Not Available
Hepatitis cholestatic09.01.01.002--Not Available
Hepatotoxicity12.03.01.008; 09.01.07.009--Not Available
Hypersensitivity10.01.03.003--
Hypotension24.06.03.002--
Laryngeal oedema22.04.02.001; 10.01.05.003; 23.04.01.005--
The 1th Page    1 2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene